Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06489184
The Real World Study of Zanubrutinib in the Treatment of Chronic Lymphocytic Leukemia in China
Sponsor: Peking University People's Hospital
View on ClinicalTrials.gov
Summary
This is a Multicenter, Retrospective Real-world Study of Zanubrutinib in the Treatment of Chronic Lymphocytic Leukemia in China
Official title: This is a Multicenter, Retrospective Real-world Study of Zanubrutinib in the Treatment of Chronic Lymphocytic Leukemia in China
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
490
Start Date
2024-08-01
Completion Date
2025-12-30
Last Updated
2024-07-05
Healthy Volunteers
No
Conditions
Interventions
DRUG
Zanubrutinib
patients with treatment naive or R/R CLL who treatment with Zanubrutinib
Locations (1)
Peking University People's Hospital
Beijing, Beijing Municipality, China